Goodpasture syndrome differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}}{{APM}}{{AE}}{{KW}} | {{CMG}}{{APM}}{{AE}}{{KW}} | ||
== Overview == | |||
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome. | |||
== Differential Diagnosis == | |||
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome. | |||
==References== | ==References== |
Revision as of 12:10, 4 November 2016
Goodpasture syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goodpasture syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Goodpasture syndrome differential diagnosis |
Risk calculators and risk factors for Goodpasture syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.
Differential Diagnosis
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.